Tanya Pulver, MD
Gynecologic Oncology · Chicago, ILNPI 1336395888
Payments from drug & device makers
What this record shows
Intuitive Surgical accounts for 74.2% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2019 at $1,106 and has fallen 94.5% since, to $61 in 2025. That places this record below the midpoint for gynecologic oncology clinicians in IL, where the typical reported total is $1,540.
Across 21 payments — averaging $74.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$1K
- AstraZeneca$148
- Myriad Genetic Laboratories, Inc.$81
- Gynesonics, Inc.$50
- Conmed Corporation$37
- Boston Scientific$29
- plus $61 from 3 others
What the payments were for
- Travel & lodging$90458%
- Food & beverage$66842%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $1,166 |
| AstraZeneca | 2 | $148 |
| Myriad Genetic Laboratories, Inc. | 4 | $81 |
| Gynesonics, Inc. | 1 | $50 |
| Conmed Corporation | 1 | $37 |
| Boston Scientific | 1 | $29 |
| Hologic Sales And Service, LLC | 1 | $29 |
| AbbVie | 1 | $17 |
| Merck | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,019
How this compares
$1,573 in reported general payments places this provider in the 50th percentile of 64 gynecologic oncology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nystatin | 12 | $124 |
| Oxycodone Hcl | 18 | $43 |
Paid to pharmacies, not to this prescriber.
Other gynecologic oncology in Chicago
- Amina AhmedChicago$1.1M
- Dario RoqueChicago$587K
- Jenna MarcusChicago$230K
- Emily HinchcliffChicago$62K
- Summer DewdneyChicago$59K
- Kathryn MillsChicago$32K
- Wilberto Nieves-NeiraChicago$23K
- Amy AlexanderChicago$22K
- Freidoon AziziChicago$14K
- John MoroneyChicago$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.